This happens through genomic activation, like germline MET mutation, such as in hereditary papillary renal cell carcinoma [8] or sporadic MET mutations, detected in various cancer types, including brain, gastric, and head and neck cancers [9] or even protein over-expression. Here, MET is linked to cancer.